|
Market Cap (17-May) $36,803,800 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (5-May) 630,735 (0.15%) (400th) |
|
52w High $0.130 |
52w Low $0.086 |
P/E 312.50 |
EPS -0.03 |
A news article has been posted about Starpharma Holdings on the AFR. The article was published around , on 23 June 2021 at 5:00am.
The bombastic biotech is facing questions from a UK regulator over claims around its COVID-19 spray nasal product. But a speed bump is nothing new.
Read ArticleSPL was $1.53 at the close of trade on 22 June 2021
| Recent Articles about ASX:SPL | |
|---|---|
| 30-Apr | Quarterly Activities Report & Appendix 4C
company-announcements.afr.com |
| 30-Apr | ASX Release Investor Presentation Share Purchase Plan closes ...
company-announcements.afr.com |
| 14-Apr | Appendix 3H - Notification of cessation of securities
company-announcements.afr.com |
| 14-Apr | Appendix 2A - Application for quotation of securities
company-announcements.afr.com |
| 2-Apr | Untitled
company-announcements.afr.com |
| 5-Mar | SPL7013 Nasal Spray Australia Update | Starpharma
company-announcements.afr.com |
| 2-Mar | Starpharma showcases DEP® dendrimer platform at PepTalk ...
company-announcements.afr.com |
| 27-Feb | Acrux Investor presentation - ASX small to mid cap conference ...
company-announcements.afr.com |
| 26-Feb | Appendix 4D: Half Year Report
company-announcements.afr.com |
| 8-Feb | SPL:ASX Announcement - Quarterly Activities/Appendix 4C Cash ...
company-announcements.afr.com |
| Tracked |
Find all articles about Starpharma Holdings, including others on the AFR, on the media page.
You must be logged in to post a reply.
Starpharma Holdings 